HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Five Years In Prison, Nearly $50M Fines For Owner Of US Lab Falsifying Sunscreen Test Results

Executive Summary

Garbriel Letizia Jr., and employees at AMA Laboratories “at his direction,” defrauded customers of more than $46m by testing products on materially lower numbers of subjects than specified and paid for by the customers.

You may also be interested in...



Owner Of Sunscreen Testing Lab AMA Awaits Sentencing Following Guilty Plea In US Federal Case

Gabriel Letizia Jr. potentially faces up to seven years in prison after admitting to defrauding AMA Laboratories customers of more than $46m by sending them bogus testing reports. The US FDA, which participated in the investigation, has not commented publicly on the implications for improperly tested sunscreens and other products.

Accused Lab Operator: Like FDA, He Didn't Find Falsified Sunscreen Results

Gabriel Letzia Jr., AMA Laboratories' owner says, "The FDA are the professionals," and he "didn’t find what the FDA couldn’t find but wound up getting indicted nevertheless."

Proposed Rule Making More OTC Switches Likely In US Makes More Tools Necessary For Sponsors

OTC drug development and marketing consultants spoke with HBW Insight about FDA’s “Nonprescription Drug Product with an Additional Condition for Nonprescription Use” proposed rule. In first of two articles, they discuss proposed rule’s likely impacts on industry and remaining concerns around incorporating extra-label information in drug labeling.

Topics

Latest News
UsernamePublicRestriction

Register

RS152542

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel